Functional characterization of 21 CYP3A4 variants on amiodarone metabolism in vitro

被引:15
|
作者
Yang, Cheng-Cheng [1 ]
Zheng, Xiang [1 ]
Liu, Teng-Hui [1 ]
Wang, Chen-Chen [1 ]
Tang, Peng-Fei [1 ]
Chen, Zhe [1 ]
Zhang, Bo-Wen [1 ]
Fang, Ping [1 ]
Hu, Guo-Xin [1 ]
Cai, Jian-Ping [2 ,3 ]
机构
[1] Wenzhou Med Univ, Sch Pharm, Wenzhou 325035, Zhejiang, Peoples R China
[2] Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China
[3] Minist Hlth, Beijing Inst Geriatr, Beijing, Peoples R China
关键词
Allelic variant; amiodarone; CYP3A4; polymorphisms; desethylamiodarone; drug metabolism; GENETIC POLYMORPHISMS; N-DEETHYLATION; IDENTIFICATION; PHARMACOKINETICS; VARIABILITY;
D O I
10.1080/00498254.2017.1414971
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1.Cytochrome P450 3A4 (CYP3A4) is an important member of the cytochrome P450 enzyme superfamily, with 33 allelic variants reported previously. Genetic polymorphisms of CYP3A4 can produce a significant effect on the efficacy and safety of some drugs, so the purpose of this study was to clarify the catalytic characteristics of 22 CYP3A4 allelic isoforms, including 6 novel variants in Han Chinese population, on the oxidative metabolism of amiodarone in vitro. 2.Wild-type CYP3A4*1 and other variants expressed by insect cells system were incubated respectively with 10-500 mu M substrate for 40 min at 37 degrees C and terminated at -80 degrees C immediately. Then these samples were treated as required and detected with ultra-performance liquid chromatography-tandem mass spectrometry used to analyze its major metabolite desethylamiodarone. 3.Among the 21 CYP3A4 variants, compared with the wild-type, the intrinsic clearance values (V-max/K-m) of two variants were apparently decreased (11.07 and 2.67% relative clearance) while twelve variants revealed markedly increased values (155.20 similar to 435.96%), and the remaining of seven variants exhibited no significant changes in enzyme activity. 4.This is the first time report describing all these infrequent alleles for amiodarone metabolism, which can provide fundamental data for further clinical studies on CYP3A4 alleles.
引用
收藏
页码:120 / 126
页数:7
相关论文
共 50 条
  • [41] Regulation of CYP3A4 by the bile acid receptor FXR:: evidence for functional binding sites in the CYP3A4 gene
    Gnerre, C
    Blättler, S
    Kaufmann, MR
    Looser, R
    Meyer, UA
    PHARMACOGENETICS, 2004, 14 (10): : 635 - 645
  • [42] Response to "Impact of CYP3A4 Genotype on Voriconazole Exposure: New Insights Into the Contribution of CYP3A4☆22 to Metabolism of Voriconazole"
    Walsh, Thomas J.
    Moriyama, Brad
    Penzak, Scott R.
    Klein, Teri E.
    Caudle, Kelly E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (02) : 187 - 187
  • [43] Pharmacogenetics of Carbamazepine: A Systematic Review on CYP3A4 and CYP3A5 Polymorphisms
    Riffi, Rachda
    Boughrara, Wefa
    Chentouf, Amina
    Ilias, Wassila
    Brahim, Narimene Malika Taieb
    Berrebbah, Amel Alioua
    Belhoucine, Fatma
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2024, 23 (12) : 1463 - 1473
  • [44] Bufalin inhibits CYP3A4 activity in vitro and in vivo
    Li, Hai-yun
    Xu, Wen
    Zhang, Xi
    Zhang, Wei-dong
    Hu, Li-wei
    ACTA PHARMACOLOGICA SINICA, 2009, 30 (05) : 646 - 652
  • [45] Bufalin inhibits CYP3A4 activity in vitro and in vivo
    Hai-yun Li
    Wen Xu
    Xi Zhang
    Wei-dong Zhang
    Li-wei Hu
    Acta Pharmacologica Sinica, 2009, 30 : 646 - 652
  • [46] Involvement of CYP3A4 and CYP2D6 in the metabolism of haloperidol
    Fang, J
    Baker, GB
    Silverstone, PH
    Coutts, RT
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 1997, 17 (02) : 227 - 233
  • [47] Involvement of CYP3A4 and CYP2D6 in the Metabolism of Haloperidol
    Jian Fang
    Glen B. Baker
    Peter H. Silverstone
    Ronald T. Coutts
    Cellular and Molecular Neurobiology, 1997, 17 : 227 - 233
  • [48] Functional characterization of wild-type and 24 CYP2D6 allelic variants on gefitinib metabolism in vitro
    Fang, Ping
    Zheng, Xiang
    He, Jiayang
    Ge, Honglei
    Tang, Pengfei
    Cai, Jianping
    Hu, Guoxin
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 1283 - 1290
  • [49] Impact of hepatic malignancy on CYP3A4 gene expression
    Fahy, Bridget N.
    Guo, Tao
    Ghose, Romi
    JOURNAL OF SURGICAL RESEARCH, 2012, 178 (02) : 768 - 772
  • [50] Regulation of CYP3A4 and CYP3A5 by a lncRNA: a potential underlying mechanism explaining the association between CYP3A4*1G and CYP3A metabolism
    Collins, Joseph M.
    Wang, Danxin
    PHARMACOGENETICS AND GENOMICS, 2022, 32 (01) : 16 - 23